Results 151 to 160 of about 24,654 (177)
Some of the next articles are maybe not open access.

Activity of AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, in imatinib-resistant bcr-abl positive lymphoid malignancies

Journal of Clinical Oncology, 2005
3015 Background: AMN107, a novel aminopyrimidine ATP-competitive inhibitor of Bcr-Abl. AMN107, is 10- to 50-fold more potent than imatinib against Bcr-Abl expressing cell lines, and is effective against most cell lines expressing imatinib-resistant Bcr-Abl mutants.
O. Ottmann   +9 more
openaire   +1 more source

Taxodione induces apoptosis in BCR-ABL-positive cells through ROS generation

Biochemical Pharmacology, 2018
Chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) are hematopoietic malignancies caused by the constitutive activation of BCR-ABL tyrosine kinase. Although direct BCR-ABL inhibitors, such as imatinib, were initially successful in the treatment of leukemia, many patients developed drug resistance over time due to the gatekeeper ...
Yuki, Uchihara   +6 more
openaire   +2 more sources

BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach

Current Oncology Reports
The purpose of this review is to summarize the most updated treatment recommendations for pediatric CML, and to discuss current areas of investigation.There is new phase 1 data to support the safety of the non-ATP competitive tyrosine kinase inhibitor (TKI) asciminib in the pediatric cohort.
Jenna M, Menger   +3 more
openaire   +2 more sources

Advances in BCR/ABL positive ALL

ADVANCES IN CELL AND GENE THERAPY, 2019
Netanel A. Horowitz, Jacob M. Rowe
openaire   +1 more source

Implicating the bcr/abl Gene in the Pathogenesis of Philadelphia Chromosome-Positive Human Leukemia

1991
Publisher Summary The hypothesis that the Philadelphia chromosome might have a causative role in human chronic myelogenous leukemia (CML) was validated by the discovery that the human homologue of the v -abl oncogene of Abelson murine leukemia virus (A-MuLV) mapped to chromosome 9q34, precisely the locus disrupted in the formation of the ...
G Q, Daley, Y, Ben-Neriah
openaire   +2 more sources

Disruption of the Bcr-Abl/Hsp90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin.

Leukemia, 2008
The Bcr-Abl fusion gene encodes for the p210(Bcr-Abl) or p185(Bcr-Abl) tyrosine kinase (TK) implicated in the pathogenesis of chronic myelogenous leukemia (CML) or acute lymphoblastic leukemia, respectively. Because Bcr-Abl TK is chaperoned by Hsp90 (90 kDa heat-shock protein), we investigated the effects of novobiocin (NB), an Hsp90 C-terminal ...
L X, Wu   +6 more
openaire   +1 more source

Bcl2 as a therapeutic target in BCR-ABL positive ALL

Klinische Pädiatrie, 2014
AK Elder   +3 more
openaire   +1 more source

Effects of a Selective Inhibitor of the Abl Tyrosine Kinase on the Growth of Bcr–Abl Positive Cells

Nature Medicine, 1996
Brian Druker   +2 more
exaly  

Home - About - Disclaimer - Privacy